LABISAN Trademark

Trademark Overview

On Monday, December 10, 2018, a trademark application was filed for LABISAN with the United States Patent and Trademark Office. The USPTO has given the LABISAN trademark a serial number of 79262248. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, October 22, 2020. This trademark is owned by Lupuca Pharma GmbH. The LABISAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals and medical preparations for the prevention of cold sores adapted for medical use; nutritional supplements for humans
labisan

General Information

Serial Number79262248
Word MarkLABISAN
Filing DateMonday, December 10, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, October 22, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Indication of Colors claimedThe color(s) red and white is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the following: a stylized design of lips in the color red above the stylized wording "Labisan" in the color red with a circular design forming the dot in the letter "i" outlined in the color red in the color white.
Goods and ServicesPharmaceuticals and medical preparations for the prevention of cold sores adapted for medical use; nutritional supplements for humans

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 11, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLupuca Pharma GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAT

Trademark Events

Event DateEvent Description
Monday, November 15, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, October 22, 2021FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 22, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, December 26, 2020NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, December 9, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 9, 2020NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, October 22, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, October 22, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, May 15, 2020REFUSAL PROCESSED BY IB
Thursday, April 9, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 9, 2020NON-FINAL ACTION E-MAILED
Thursday, April 9, 2020NON-FINAL ACTION WRITTEN
Tuesday, March 3, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 3, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 3, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 3, 2020ASSIGNED TO LIE
Tuesday, February 18, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 18, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 18, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 18, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 18, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 18, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 6, 2019REFUSAL PROCESSED BY IB
Monday, August 19, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, August 19, 2019REFUSAL PROCESSED BY MPU
Tuesday, July 23, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, July 22, 2019NON-FINAL ACTION WRITTEN
Tuesday, July 16, 2019APPLICATION FILING RECEIPT MAILED
Thursday, July 11, 2019ASSIGNED TO EXAMINER
Thursday, July 11, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 4, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

labisan medical nutritional supplements humans adapted cold preparations prevention pharmaceuticals sores